Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT

T Czerw; M Labopin; S Giebel; G Socie; L Volin; N Fegueux; T Masszi; D Blaise; S Chaganti; Jan Cornelissen; J Passweg; J Maertens; M Itala-Remes; D Wu; M Mohty; A Nagler

doi:10.1002/cncr.31354

Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT

T Czerw, M Labopin, S Giebel, G Socie, L Volin, N Fegueux, T Masszi, D Blaise, S Chaganti, Jan Cornelissen, J Passweg, J Maertens, M Itala-Remes, D Wu, M Mohty, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

22 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2523-2533
Number of pages	11
Journal	Cancer
Volume	124
Issue number	12
DOIs	https://doi.org/10.1002/cncr.31354
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1002/cncr.31354

http://hdl.handle.net/1765/105571

Cite this

Czerw, T., Labopin, M., Giebel, S., Socie, G., Volin, L., Fegueux, N., Masszi, T., Blaise, D., Chaganti, S., Cornelissen, J., Passweg, J., Maertens, J., Itala-Remes, M., Wu, D., Mohty, M., & Nagler, A. (2018). Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT. Cancer, 124(12), 2523-2533. https://doi.org/10.1002/cncr.31354

Czerw, T ; Labopin, M ; Giebel, S et al. / Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT. In: Cancer. 2018 ; Vol. 124, No. 12. pp. 2523-2533.

@article{84414a8026694fdcb0e28f79e03b3811,

title = "Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT",

author = "T Czerw and M Labopin and S Giebel and G Socie and L Volin and N Fegueux and T Masszi and D Blaise and S Chaganti and Jan Cornelissen and J Passweg and J Maertens and M Itala-Remes and D Wu and M Mohty and A Nagler",

year = "2018",

doi = "10.1002/cncr.31354",

language = "Undefined/Unknown",

volume = "124",

pages = "2523--2533",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

number = "12",

}

Czerw, T, Labopin, M, Giebel, S, Socie, G, Volin, L, Fegueux, N, Masszi, T, Blaise, D, Chaganti, S, Cornelissen, J, Passweg, J, Maertens, J, Itala-Remes, M, Wu, D, Mohty, M & Nagler, A 2018, 'Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT', Cancer, vol. 124, no. 12, pp. 2523-2533. https://doi.org/10.1002/cncr.31354

Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT. / Czerw, T; Labopin, M; Giebel, S et al.
In: Cancer, Vol. 124, No. 12, 2018, p. 2523-2533.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT

AU - Czerw, T

AU - Labopin, M

AU - Giebel, S

AU - Socie, G

AU - Volin, L

AU - Fegueux, N

AU - Masszi, T

AU - Blaise, D

AU - Chaganti, S

AU - Cornelissen, Jan

AU - Passweg, J

AU - Maertens, J

AU - Itala-Remes, M

AU - Wu, D

AU - Mohty, M

AU - Nagler, A

PY - 2018

Y1 - 2018

U2 - 10.1002/cncr.31354

DO - 10.1002/cncr.31354

M3 - Article

C2 - 29603136

SN - 0008-543X

VL - 124

SP - 2523

EP - 2533

JO - Cancer

JF - Cancer

IS - 12

ER -

Czerw T, Labopin M, Giebel S, Socie G, Volin L, Fegueux N et al. Anti-Thymocyte Globulin Improves Survival Free From Relapse and Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Philadelphia-Negative Acute Lymphoblastic Leukemia: An Analysis by the Acute Leukemia Working Party of the EBMT. Cancer. 2018;124(12):2523-2533. doi: 10.1002/cncr.31354